Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer

Title
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 79, Issue 9, Pages 2327-2338
Publisher
American Association for Cancer Research (AACR)
Online
2019-05-01
DOI
10.1158/0008-5472.can-18-1785

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now